OLMEXA 25 MT
OLMEXA 25 MT is used for effective management of hypertension and cardiovascular risk. It contains Olmesartan Medoxomil 20 mg + Metoprolol Succinate 25 mg, offering dual action for better blood pressure control. Olmesartan relaxes blood vessels by blocking angiotensin II, while Metoprolol reduces heart rate and cardiac workload. This combination helps maintain stable blood pressure, supports heart health, and is commonly prescribed for long-term cardiovascular protection.
Related products
TELLME 80 CT
TELLME 80 CT contains Telmisartan 80 mg + Chlorthalidone 12.5 mg. Telmisartan helps relax blood...
TELLME TRIO CC
TELLME CC combines Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg. This...
TELLME 40 CL
TELLME 40 CL is a combination of Telmisartan 40 mg + Cilnidipine 10 mg. Telmisartan...
TELLME AM
Composition : Telmisartan 40 mg + Amlodipine 5 mg
